Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
1.0%
1w
7.6%
1m
19.9%
3m
38.4%
6m
4.8%
1y
44.4%
all
9.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 505 1.0%
325
524
Company Overview

Sales
947 Cr
Growth: 0.8%
Profit after Tax
248 Cr
Growth: -15.6%
Mid Cap
8,765 Cr
P/E: 35.3x
Industry P/E: 31.3x
Fundamentals

Sales (Cr) ₹ 947
Growth 0.8%
EBITDA 31.0%
P/S 9.3x
Dividend 0.2%
P/E 35.3x
Book Value ₹ 78.4
PEG Ratio 46.7x
ROE 19.1%
P/B 6.5x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)